Alveo Wins XPRIZE Rapid Covid-19 Testing Competition. Click
here to read the news.
May 12, 2021
Roche executive Neil Gunn brings quarter-century of commercialization experience to infectious disease testing innovator Alameda, Calif. – May 13, 2021 – Alveo Technologies, Inc., an infectious disease testing leader, announced today biotechnology, diagnostics and...
Mar 16, 2021
Prestigious honor validates potential of Alveo’s low-cost, accessible COVID-19 testing technology as company prepares for commercialization Click to watch how the be.well™ COVID-19 Test works. Alameda, Calif. – March 17, 2021 – Alveo Technologies, Inc. (Alveo)...
Feb 10, 2021
– The CE Mark for the Alveo be.well COVID-19 Flex Test is Alveo’s first regulatory approval- Alveo plans to submit the test for approval by the U.S. Food and Drug Administration under emergency use authorization Alameda, CA – 02/10/21 – Alveo Technologies, Inc....
Nov 2, 2020
Infectious Disease Diagnostic Innovator Receives Grant from the Bill & Melinda Gates Foundation to Advance Accessibility and Commercialization for At-Home COVID-19 Testing Alameda, CA – 11/2/20 – Alveo Technologies, today announced it has been awarded a grant to...
Sep 14, 2020
Cutting-Edge Infectious Disease Diagnostics Company Brings on Former Aetna EVP to Drive Business Strategy and Support Widespread Adoption of Diagnostic Platform Alameda, CA – September 15, 2020 – Alveo Technologies, a leader in developing novel technologies that...
Aug 17, 2020
Seasoned Healthcare Financial Expert to Drive Strategic Growth for Diagnostic Tech Startup Alameda, CA – August 18, 2020 – Alveo Technologies, a leader in developing noveltechnologies that enable real-time, low-cost, at-home molecular detection of infectious disease,...
Jul 6, 2020
Researcher Lends Clinical Expertise to Evaluate New Diagnostic Technologies and Support Science Research Alameda, CA – July 7, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of...
May 11, 2020
Biopharma Leader to Provide Expertise to Develop and Deliver World’s First At-Home Rapid Test for Respiratory Viral Infections Alameda, CA – May 12, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost...
Apr 30, 2020
Alameda, CA – April 30, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, announced today that it has entered into a research collaboration with Janssen...
Feb 20, 2020
We are thrilled to announce today that in February 2020 Alveo Technologies was presented with a Food and Drug Branch License (FDB License) after an in-person inspection by a Food and Drug Investigator from the State of California Food and Drug Branch of the Food and...
